| abstract |
Disclosed is a pharmaceutical combination for the treatment or prevention of proliferative diseases. A) a specific pyrimidylaminobenzamide compound, or N-oxide or a pharmaceutically acceptable salt of the compound, and b) a Thr315Ile kinase inhibitor selected from a specific group of compounds. A pharmaceutical combination comprising. Use of the pharmaceutical combination in the manufacture of a medicament for the treatment or prevention of proliferative diseases. The proliferative disease is selected from tumor, leukemia, psoriasis, restenosis, scleroderma, fibrosis. [Selection figure] None |